New Breast Cancer Drug Afinitor Shows Trend Of Extending Survival

Novartis received approval last week for Afinitor to be used to combat breast cancer.  The drug already has approval for tumors of the kidney and pancreas. 

It's showing more significant benefit, but it's also not making people as sick as some of the other therapies.

Click here to read more...

Triple Pink Turns 5!

Today marks Triple Pink's 5th Anniversary! 

We're so grateful for the awesome support that we've received from all of our volunteers and donors.  We have been very fortunate to sponsor some great programs in the past and are looking forward to another 5...make that, 50+ years!